The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma
Journal of Oncology Pharmacy Practice · 14.11.2026
DOI: 10.1177/10781552261506798 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 14.11.2026. Verfasst von Duygu Ercan Uzundal. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye. Die Arbeit nennt 4 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye.
ORCID-Profile: Duygu Ercan Uzundal
Zitieren
APA
Ercan Uzundal, D. (2026). The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261506798
Vancouver
Ercan Uzundal D. The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261506798
BibTeX
@article{ErcanUzundal2026,
author = {Ercan Uzundal, Duygu},
title = {The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma},
journal = {Journal of Oncology Pharmacy Practice},
year = {2026},
doi = {10.1177/10781552261506798}
}
EUVIMED